Accessibility Menu
Nevro logo

Nevro(NYSE) NVRO

This security has been delisted. This page is retained for historical reference.

Nevro last closing stock price
MetricPriceDate
Last closeUSD 5.842025-04-02
Nevro stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-0.17%USD 5.852025-03-26
1 month+2.1%USD 5.722025-03-03
3 month+57.41%USD 3.712025-01-02
Year to date+56.99%USD 3.722024-12-31
1 year-54.12%USD 12.732024-04-02
3 year-92.36%USD 76.422022-04-01
5 year-93.78%USD 93.962020-04-03
Since inception-76.82%USD 25.192014-11-06

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

NVRO Financials

Key Financial Metrics (TTM)

Gross Margin

65.98%

Operating Margin

-30.90%

Net Income Margin

-27.77%

Return on Equity

-43.28%

Return on Capital

-26.18%

Return on Assets

-20.48%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

N/A

Volume

N/A

Avg. Volume

N/A

Financials (TTM)

Gross Profit

$265.56M

Operating Income

-$122.76M

EBITDA

-$71.35M

Operating Cash Flow

-$19.77M

Capital Expenditure

-$9.79M

Free Cash Flow

-$29.49M

Cash & ST Invst.

$292.53M

Total Debt

$251.16M

Nevro Performance Analysis

Nevro annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20212021-12-31USD 386,905,000N/A
20222022-12-31USD 406,365,0005.0%
20232023-12-31USD 425,174,0004.6%
20242024-12-31USD 408,518,000-3.9%
Nevro sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q12024-03-31-12.3%
Q22024-06-302.2%
Q32024-09-30-7.0%
Q42024-12-318.9%
Nevro annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20212021-12-31USD -3.77N/A
20222022-12-31USD 0.08N/A
20232023-12-31USD -2.56N/A
20242024-12-31USD -3.0619.3%
Nevro sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q12024-03-31-180.0%
Q22024-06-3024.3%
Q32024-09-3022.6%
Q42024-12-31-243.9%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2024YOY CHG

Revenue

$105.55M

-9.1%

Gross Profit

$65.92M

-16.0%

Gross Margin

62.45%

N/A

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

N/A

N/A

Employees

1,099

N/A

Net Income

-$53.11M

-491.4%

EBITDA

-$43.01M

-359.0%

Quarterly Fundamentals

Name
Q4 2024YOY CHG

Total Cash

$292.53M

-9.4%

Total Debt

$251.16M

+13.2%

Accounts Receivable

$71.88M

-9.4%

Inventory

$103.27M

-13.0%

Long Term Debt

$213.19M

-1.3%

Short Term Debt

$37.97M

+563.6%

Return on Assets

-20.48%

N/A

Return on Invested Capital

-28.00%

N/A

Free Cash Flow

$16.60M

+199.9%

Operating Cash Flow

$18.60M

+226.0%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
SNDASonida Senior Living, Inc.
$40.00-3.47%
BSGMBioSig Technologies, Inc.
$6.10+37.08%
TCRTAlaunos Therapeutics, Inc.
$1.95-6.70%
SLRNAcelyrin, Inc.
$2.27+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
TAT&T
$23.04+0.04%
ONDSOndas
$8.00+0.04%
SMCISuper Micro Computer
$30.56+0.20%
AALAmerican Airlines Group
$14.79-0.03%

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.